Report period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
JNJ:US | Johnson & Johnson | Common share | - | US4781601046 | $157.2 |
Company name | Johnson & Johnson |
---|---|
Tags | #pharmacy, #s&p500 index |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455 |
Mailing address | ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 |
Website | www.investor.jnj.com |
Information disclosure | www.sec.gov |